Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial-Reference-Cited by-同舟云学术

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Published:2015-07-01 Issue:2 Volume:24 Page:675-682
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Abe Masakazu,Hirashima Yasuyuki,Kasamatsu Yuka,Kado Nobuhiro,Komeda Satomi,Kuji Shiho,Tanaka Aki,Takahashi Nobutaka,Takekuma Munetaka,Hihara Hanako,Ichikawa Yoshikazu,Itonaga Yui,Hirakawa Tomoko,Nasu Kaei,Miyagi Kanoko,Murakami Junko,Ito Kimihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-2829-z.pdf

Reference33 articles.

1. Bloechl-Daum B, Deuson RR, Mavros P, et al. (2006) Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. Clin Oncol 24:4472–4478

2. MASCC/ESMO Antiemetic Guideline 2013. http://www.mascc.org/assets/documents/mascc_guidelines_english_2013.pdf Accessed 20 Mar. 2015.

3. Basch E, Prestrud AA, Hesketh PJ, et al. (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189–4198

4. National Comprehensive Cancer Network (2014) NCCN clinical practice guidelines in oncology: antiemesis, Version 1. http:// www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf Accessed 20 Mar. 2015.

5. Japan Society of Clinical Oncology (2014) Guidelines for the proper use of antiemetics, version 1.2. Kanehara, Tokyo.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-;Investigational New Drugs;2023-12-06

2. Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients;Al Mustansiriyah Journal of Pharmaceutical Sciences;2023-05-22

3. Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting;Hong Kong Medical Journal;2023-02-20

4. Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug;Current Oncology;2022-10-31

5. Addition of olanzapine to standard chemotherapy-induced nausea and vomiting prophylaxis in hematopoietic stem cell transplant;2022-09-29